Steven Hunt, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 206 E Smith St, Iron Mountain, MI 49801 Phone: 906-779-0010 Fax: 906-779-0009 |
News Archive
Mr. Brian Pedlar, President and CEO of Covalon Technologies Ltd., an advanced medical technologies company, is pleased to provide the following update.
E. Fougera & Co., a leading specialty pharmaceutical manufacturer, announced it has received first generic approval from the FDA for Adapalene Cream 0.1% (Rx). Fougera's Adapalene Cream 0.1% is rated AB, generically equivalent to Differin® by Galderma Pharmaceuticals. According to industry data, U.S. sales of the brand named product in 2009 exceeded $55 million. This approval also marks the fourth product approval that the FDA has granted to Fougera this year.
Over the last years, two teams of researchers at The Scripps Research Institute have steadily built a model of how a powerful DNA repair complex works. Now, their latest discovery provides revolutionary insights into the way the molecular motor inside the complex functions - findings they say may have implications for treatment of disorders ranging from cancer to cystic fibrosis.
Exposure to radiation from imaging equipment is constantly subjected to scrutiny from regulatory authorities. Ultrasound poses no radiation threat and is constantly further developed to accentuate primary and secondary diagnosis. The next wave in ultrasound technology will witness advancements in Elastography and Contrast Enhanced Ultrasound (CEUS) for diagnosis.
› Verified 6 days ago